camostat has been researched along with op 41483-alpha-cyclodextrin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchinoue, S; Honda, H; Kawai, T; Sanaka, T; Takahashi, K; Tanabe, K; Teraoka, S; Toma, H; Yagisawa, T; Yamaguchi, Y | 1 |
1 other study(ies) available for camostat and op 41483-alpha-cyclodextrin
| Article | Year |
|---|---|
New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation.
Topics: alpha-Cyclodextrins; Benzamidines; Blood Platelets; Cyclodextrins; Epoprostenol; Esters; Gabexate; Graft Rejection; Guanidines; Humans; Kidney; Kidney Transplantation; Vascular Diseases | 1987 |